RDHL
Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)
RDHL Filings
Filing Date
Form Description
Form Type
2026-02-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-28
Form EFFECT - Notice of Effectiveness
2026-01-28 ·
Form EFFECT - Notice of Effectiveness
2026-01-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-22
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-01-22 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-01-22
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026-01-22 ·
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026-01-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-31
Form F-1 - Registration statement for certain foreign private issuers
2025-12-31 ·
Form F-1 - Registration statement for certain foreign private issuers
2025-12-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-31 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-23
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-23 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
